Early drug test probes Body's salt control system
NCT ID NCT06649409
Summary
This early-stage study aimed to understand if an experimental drug called vamorolone can block a specific receptor in the body that helps regulate salt and water balance. It involved 30 healthy volunteers who received either vamorolone, a comparison drug, or no treatment, alongside a challenge to stimulate the receptor. The main goal was to measure changes in urine salts to see how well vamorolone worked and to check its safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACODYNAMIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nuvisan GmbH
Neu-Ulm, 89231, Germany
Conditions
Explore the condition pages connected to this study.